Bank of New York Mellon’s Tetraphase Pharmaceuticals, Inc. TTPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q3 | – | Sell |
-23,117
| Closed | -$58K | – | 4193 |
|
|
2020
Q2 | $58K | Sell |
23,117
-5,035
| -18% | -$9.54K | ﹤0.01% | 3966 |
|
|
2020
Q1 | $36K | Buy |
+28,152
| New | +$57.5K | ﹤0.01% | 4010 |
|
|
2019
Q3 | – | Sell |
-5,271
| Closed | -$51K | – | 4273 |
|
|
2019
Q2 | $51K | Sell |
5,271
-5,886
| -53% | -$108K | ﹤0.01% | 4119 |
|
|
2019
Q1 | $299K | Buy |
11,157
+689
| +7% | +$17.5K | ﹤0.01% | 3743 |
|
|
2018
Q4 | $237K | Sell |
10,468
-32
| -0.3% | -$1.25K | ﹤0.01% | 3794 |
|
|
2018
Q3 | $580K | Sell |
10,500
-3,999
| -28% | -$255K | ﹤0.01% | 3570 |
|
|
2018
Q2 | $1.03M | Buy |
14,499
+2,467
| +21% | +$174K | ﹤0.01% | 3225 |
|
|
2018
Q1 | $738K | Buy |
12,032
+289
| +2% | +$25.4K | ﹤0.01% | 3375 |
|
|
2017
Q4 | $1.48M | Sell |
11,743
-22
| -0.2% | -$2.82K | ﹤0.01% | 3015 |
|
|
2017
Q3 | $1.61M | Buy |
11,765
+2,058
| +21% | +$275K | ﹤0.01% | 2957 |
|
|
2017
Q2 | $1.38M | Buy |
9,707
+312
| +3% | +$48.2K | ﹤0.01% | 3058 |
|
|
2017
Q1 | $1.73M | Buy |
9,395
+306
| +3% | +$34.3K | ﹤0.01% | 2934 |
|
|
2016
Q4 | $732K | Buy |
9,089
+1,671
| +23% | +$132K | ﹤0.01% | 3431 |
|
|
2016
Q3 | $569K | Sell |
7,418
-1,160
| -14% | -$92.9K | ﹤0.01% | 3473 |
|
|
2016
Q2 | $738K | Sell |
8,578
-1,555
| -15% | -$142K | ﹤0.01% | 3342 |
|
|
2016
Q1 | $938K | Buy |
10,133
+2,031
| +25% | +$203K | ﹤0.01% | 3097 |
|
|
2015
Q4 | $1.63M | Buy |
8,102
+118
| +1% | +$23.5K | ﹤0.01% | 2844 |
|
|
2015
Q3 | $1.19M | Sell |
7,984
-3,542
| -31% | -$2.6M | ﹤0.01% | 3078 |
|
|
2015
Q2 | $10.9M | Buy |
11,526
+1,451
| +14% | +$1.19M | ﹤0.01% | 1920 |
|
|
2015
Q1 | $7.38M | Buy |
10,075
+1,004
| +11% | +$754K | ﹤0.01% | 2099 |
|
|
2014
Q4 | $7.2M | Buy |
9,071
+1,744
| +24% | +$939K | ﹤0.01% | 2110 |
|
|
2014
Q3 | $2.92M | Buy |
7,327
+2,909
| +66% | +$779K | ﹤0.01% | 2623 |
|
|
2014
Q2 | $1.19M | Buy |
4,418
+1,066
| +32% | +$229K | ﹤0.01% | 3211 |
|
|
2014
Q1 | $730K | Buy |
3,352
+678
| +25% | +$189K | ﹤0.01% | 3431 |
|
|
2013
Q4 | $723K | Buy |
2,674
+1,043
| +64% | +$249K | ﹤0.01% | 3445 |
|
|
2013
Q3 | $371K | Sell |
1,631
-7
| -0.4% | -$1.22K | ﹤0.01% | 3621 |
|
|
2013
Q2 | $230K | Buy |
+1,638
| New | +$259K | ﹤0.01% | 3740 |
|
Bank of New York Mellon's TTPH Position: Q3 2020 in Review
Bank of New York Mellon sold out of Tetraphase Pharmaceuticals, Inc. (TTPH) in Q3 2020, closing a stake of 23,117 shares — an estimated $58K sold.
Bank of New York Mellon first reported a position in TTPH in Q2 2013 and held it in 27 quarters. The position peaked at $10.9M in Q2 2015. 1 fund tracked by Wall St. Rank holds TTPH as of Q3 2020.
- Bank of New York Mellon reported no remaining Tetraphase Pharmaceuticals, Inc. position as of Q3 2020 after selling out during the quarter.
- Bank of New York Mellon sold 23,117 Tetraphase Pharmaceuticals, Inc. shares in Q3 2020, an estimated $58K.
- Bank of New York Mellon first reported a position in Tetraphase Pharmaceuticals, Inc. in Q2 2013 and held it in 27 quarters.
- Bank of New York Mellon's Tetraphase Pharmaceuticals, Inc. position peaked at $10.9M in Q2 2015.
- 1 fund tracked by Wall St. Rank held Tetraphase Pharmaceuticals, Inc. as of Q3 2020.
Based on Bank of New York Mellon's 13F filing for Q3 2020, filed 12 Nov 2020.